Intended Use

ProFound Detection V4.0 is a computer-assisted detection and diagnosis (CAD) software device intended to be used concurrently by interpreting physicians while reading digital breast tomosynthesis (DBT) exams from compatible DBT systems. The system detects soft tissue densities (masses, architectural distortions and asymmetries) and calcifications in the 3D DBT slices. The detections and Certainty of Finding and Case Scores assist interpreting physicians in identifying soft tissue densities and calcifications that may be confirmed or dismissed by the interpreting Physician.

Technology

ProFound Detection V4.0 utilizes neural network architectures for image processing and AISupported CAD of DBT images, assigning Certainty of Finding and Case Scores which indicate the algorithm's confidence of malignancy in each finding and case. It includes a Predetermined Change Control Plan (PCCP) to extend support to multiple DBT image acquisition systems with algorithm training, tuning, and locking prior to commercial release.

Performance

Performance testing demonstrated that ProFound Detection V4.0 is non-inferior and in some measures superior to the predicate device (ProFound AI V3.0), with sensitivity around 90% and improved specificity. Testing involved retrospective evaluation of 952 DBT cases with biopsy-proven cancers and various demographics, using clinical reference standards. Unit and integration testing confirmed expected results.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    2/13/2024

    8 months
  • 2

    FDA Approval

    11/8/2024

Other devices from iCAD, Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.